Advertisement
U.S. markets closed

Aytu BioPharma, Inc. (AYTU)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.0400-0.0400 (-1.30%)
At close: 04:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts1111
Avg. Estimate-0.64-0.06-2.230.5
Low Estimate-0.64-0.06-2.230.5
High Estimate-0.64-0.06-2.230.5
Year Ago EPS-1.93-0.59-5.11-2.23
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts1111
Avg. Estimate17.35M21.17M83.55M77.08M
Low Estimate17.35M21.17M83.55M77.08M
High Estimate17.35M21.17M83.55M77.08M
Year Ago SalesN/A30.73M107.4M83.55M
Sales Growth (year/est)N/A-31.10%-22.20%-7.70%
Earnings History3/30/20236/29/20239/29/202312/30/2023
EPS Est.-0.63-0.95-0.04-0.25
EPS Actual-1.93-0.59-1.48-0.04
Difference-1.30.36-1.440.21
Surprise %-206.30%37.90%-3,600.00%84.00%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.64-0.06-2.230.5
7 Days Ago-0.64-0.06-2.230.5
30 Days Ago-0.64-0.06-2.230.5
60 Days Ago-0.480.04-2.170.62
90 Days Ago-0.480.04-2.170.62
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAYTUIndustrySector(s)S&P 500
Current Qtr.66.80%N/AN/AN/A
Next Qtr.89.80%N/AN/AN/A
Current Year56.40%N/AN/AN/A
Next Year122.40%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A